The Medical Letter on Drugs and Therapeutics
Clenpiq - A Low-Volume Sodium Picosulfate-Based Colonoscopy Preparation
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.

The FDA has approved Clenpiq (Ferring), a low-volume oral solution that contains sodium picosulfate, magnesium oxide, and anhydrous citric acid, for colon cleansing prior to colonoscopy in adults. The ready-to-drink solution contains the same ingredients as Prepopik, which is supplied as a powder for reconstitution.

COLONOSCOPY PREPARATIONS — Colonoscopy is the preferred method for colorectal cancer screening in the US. Many patients consider cleansing the bowel in preparation for colonoscopy the most unpleasant part of the procedure, but inadequate bowel preparation significantly lowers diagnostic yield.1-3

Colonoscopy preparations containing polyethylene glycol (PEG) plus electrolytes have demonstrated efficacy and safety, but they require patients to ingest up to 4 L of fluid to produce a cathartic effect.4 ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Clenpiq - A Low-Volume Sodium Picosulfate-Based Colonoscopy Preparation
Article code: 1547b
 Electronic, downloadable article - $45
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
Recommend to your librarian